ACCENTIA BIOPHARMACEUTICALS INC Increase (Decrease) in Accrued Liabilities
ACCENTIA BIOPHARMACEUTICALS INC reported Increase (Decrease) in Accrued Liabilities of $4.21 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2012-12-26
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for the quarter ending 2012-09-30 was $1.48M, a 45.84% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for the quarter ending 2012-06-30 was $1.56M, a 27.83% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for the quarter ending 2012-03-31 was $52.89K, a 93.34% decline year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $1.12M, a 732.45% increase year-over-year.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for fiscal 2012 was $4.21M, a 33.25% increase from fiscal 2011.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for fiscal 2011 was $3.16M, a 47.03% decline from fiscal 2010.
- ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in accrued liabilities for fiscal 2010 was $5.96M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2012-09-30 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $3.03M derived: sum of 2 quarters · filed 2012-12-26 | $3.08M derived: sum of 3 quarters · filed 2012-12-26 | $4.21M 10-K · filed 2012-12-26 |
| 2012-06-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | $1.61M derived: sum of 2 quarters · filed 2012-08-14 | $2.73M 10-Q · filed 2012-08-14 | $3.74M derived: sum of 4 quarters · filed 2012-12-26 |
| 2012-03-31 | $52.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $1.18M 10-Q · filed 2012-05-15 | $2.19M derived: sum of 3 quarters · filed 2012-12-26 | $3.40M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-12-31 | $1.12M 10-Q · filed 2012-02-10 | $2.14M derived: sum of 2 quarters · filed 2012-12-26 | $3.35M derived: sum of 3 quarters · filed 2012-12-26 | $4.15M derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-09-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26 | $2.23M derived: sum of 2 quarters · filed 2012-12-26 | $3.02M derived: sum of 3 quarters · filed 2012-12-26 | $3.16M 10-K · filed 2012-12-26 |
| 2011-06-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14 | $2.01M derived: sum of 2 quarters · filed 2012-08-14 | $2.15M 10-Q · filed 2012-08-14 | $5.07M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $794.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15 | $929.19K 10-Q · filed 2012-05-15 | $3.85M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $135.00K 10-Q · filed 2012-02-10 | $3.06M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19 | $5.96M 10-K · filed 2011-12-19 | ||
| 2010-06-30 | $3.04M 10-Q · filed 2011-08-12 |